We constructed a full-length human P2X 5 purinoceptor cDNA by incorporating a sequence corresponding to exon 10, which is missing in cDNAs cloned previously from human tissues. We studied the functional properties by patch-clamp recording and fluorescence imaging after expression in human embryonic kidney 293 cells. ATP (1-100 M; half-maximal current at 4 M) elicited inward currents at Ϫ60 mV; these persisted during brief (2 s) applications but declined during longer applications. The peak current was dependent on the holding potential and showed little rectification; however, both the desensitization during the application and the decline in the current when ATP was washed out were slower at ϩ30 mV than at Ϫ60 mV. 2Ј,3Ј-O-(4-Benzoyl)-benzoyl-ATP and ␣␤-methylene-ATP mimicked the action of ATP (half-maximal concentrations 6 and 161 M, respectively). The currents were inhibited by suramin, pyridoxal-5-phosphate-6-azo-2Ј,4Ј-disulfonic acid and Brilliant Blue G, with half-maximal inhibition at 3, 0.2, and 0.5 M, respectively; 2Ј,3Ј-O-(2Ј,4Ј,6Ј-trinitrophenol)-ATP (1 M) was ineffective. Removing divalent cations did not significantly alter ATP concentration-response curves. Reversal potential measurements showed that the human P2X 5 receptor was permeable to calcium (P Ca /P Na ϭ 1.5) and N-methyl-D-glucamine (NMDG) (P NMDG /P Na ϭ 0.4); it was also permeable to chloride (P Cl /P Na ϭ 0.5) but not gluconate (P gluc /P Na ϭ 0.01) ions. The permeability to NMDG developed as quickly as the channel opened, in contrast to the P2X 7 receptor where the NMDG permeability develops over several seconds. Cells expressing human P2X 5 receptors also rapidly accumulated the propidium dye YO-PRO-1 in response to ATP.
A P2X 5 subunit cDNA was first isolated from libraries of rat sympathetic ganglia (Collo et al., 1996) and heart (Garcia-Guzman et al., 1996) . The RNA is expressed predominantly in heart (Garcia-Guzman et al., 1996) but there is also expression in brain, spinal cord, and adrenal gland (GarciaGuzman et al., 1996) . Immunoreactivity for P2X 5 subunits has also been described in developing skeletal muscle of the rat (Meyer et al., 1999; Ryten et al., 2001) ; recently, the receptor has been implicated in the differentiation of satellite cells into mature multinucleated muscle fibers (Ryten et al., 2002) . Mammalian skin and endocrine (Glass and Burnstock, 2001 ) cells also show P2X 5 immunoreactivity.
When expressed in HEK293 cells, the rat P2X 5 subunit cDNAs gave rise to currents activated by ATP, but these were very small and their properties not extensively studied. The current was elicited by ATP [half-maximal concentration (EC 50 ) about 10 M] but not by ␣␤meATP, and it was readily blocked by suramin and PPADS in the 1 to 10 M concentration range (Collo et al., 1996; Garcia-Guzman et al., 1996) . A mouse cDNA has also been cloned and expressed; again, the currents recorded from HEK293 cells were only a few tens of picoamperes and they were not studied in detail ). On the other hand, although these two mammalian receptors do not express well as homomeric channels, their coexpression with P2X 1 subunits leads to the appearance of a large membrane current with several distinct properties indicative of a functional P2X 1 /P2X 5 heteromer (Torres et al., 1998; Lê et al., 1999; Surprenant et al., 2000) . Three nonmammalian vertebrate P2X 5 receptor subunits have recently been cloned. The zebrafish (Danio rerio) receptor expressed very poorly in HEK293 cells, even though the zebrafish P2X 4 receptor gave good currents in parallel exper-iments (Diaz-Hernandez et al., 2002) . The bullfrog (Rana catesbeiana) receptor cloned from larval skin and the chicken (Gallus gallus) receptor cloned from skeletal muscle provided substantive currents in HEK293 cells (Ruppelt et al., 2001) and Xenopus laevis oocytes (Bo et al., 2000; Jensik et al., 2001) . These nonmammalian receptors share basic pharmacological properties with their mammalian counterparts (e.g., sensitivity to PPADS and suramin) but also exhibit some interesting features not seen in the limited prior studies of the mammalian receptors. For example, Soto's group (Ruppelt et al., 2001) showed that the homomeric chicken P2X 5 receptor was significantly permeable to chloride ions, and Jensik et al. (2001) found that the bullfrog receptor became permeable to NMDG and propidium iodide when divalent cations were removed from the solution.
The human P2X 5 receptor cDNA was isolated from brain, and its RNA was particularly enriched in thymus and other immune cells (Lê et al., 1997) . However, alignment with other members of the P2X families showed that this cDNA lacked exon 10. This form was originally designated P2X 5A ; P2X 5B also misses exon 3 (GenBank accession number Q93086). Exon 10 encodes a 22-amino acid segment of protein including much of the second of the two membranespanning domains. This cDNA did not encode functional channels, but a chimeric receptor in which the C-terminal region of the rat receptor (starting at the position equivalent to the beginning of exon 10) was joined to the human receptor provided robust ATP-activated currents when expressed in X. laevis oocytes (Lê et al., 1997) .
The human P2X 5 gene occupies about 21 kilobases near the end of the short arm of chromosome 17 (p13.3). We found a sequence corresponding to exon 10 of the P2X 5 receptor at the appropriate place in the gene (NCBI contig NT 010692, bases 3,048,945-3,049,010) . However, the sequence at the 3Ј splice site (GGTGCTgggagt) contains gg on the intronic side rather than the gt, which is the consensus for RNA splicing; gt is found at the corresponding position in the mouse ) and chick (Ruppelt et al., 2001 ) genomic sequences. Remarkably, a single nucleotide polymorphism at precisely this position has been reported (position 3,049,012; NCBI dbSNP ss1321072). In persons with thymidine, exon 10 will be recognized during processing of the P2X 5 receptor mRNA and this will be translated to a 'full-length' receptor; persons with guanine at this position will make a receptor that does not include exon 10. Most expressed sequence tags in the dbEST database that contain appropriate fragments of the P2X 5 receptor show that exon 10 is missing, but there are cases in which it is present (GenBank accession numbers BG116171, duodenal adenocarcinoma; AW402829, B cell germinal center). In the current release of dbEST, 12 ESTs are missing exon 10, and two ESTs contain it; this provides a crude estimate of the frequency of the G Ͼ T polymorphism of 14%.
We therefore undertook to construct and express a fulllength human P2X 5 receptor cDNA. This seemed to be a worthwhile goal in view of 1) the widespread tissue distribution of the subunit, 2) the limited expression studies of other mammalian homomeric P2X 5 receptors, 3) the interesting properties of the channels formed by the chick and bullfrog subunits, and 4) the indication from genomic sequence and ESTs that the 'exon 10-containing' receptor will in fact be made by a subset of individuals.
Materials and Methods
Construction of Full-Length Human P2X 5 cDNA. Several hP2X 5 receptor-related cDNA sequences were identified by a BLAST search of human dbEST database with the coding region of hP2X 5 cDNA (GenBank accession number AF016709). One of the clones from a human lung small cell carcinoma was purchased (GenBank accession number BE791872; Incyte Genomics Inc., Palo Alto, CA) and sequenced. A TBLASTN search of human genomic DNA with the exon 10 sequence of rat P2X 5 cDNA identified a corresponding sequence (AF168787, translation is Ala 325 -Gly-Lys-Phe-Ser-Ile-Ile-Pro-Thr-IleIle-Asn-Val-Gly-Ser-Gly-Val-Ala-Leu-Met-Gly-Ala, which has three conservative differences from the equivalent rat sequence) (Fig. 1A) . To produce the full-length hP2X 5 receptor, the cDNA of the EST clone was subcloned from the original pOTB7 vector into pRS7T vector with EcoRI and XhoI. The 5Ј nontranslated region was removed by digesting with NcoI and the plasmid was religated. To insert the missing exon 10 into the modified EST clone, the following four primers were used for overlap extension-based mutagenesis: 5Ј-cccaccatcatcaacgtgggctctggggtggcgctcatgggtgctggtgctttcttctgcgacctg, 5Ј-agagcccacgttgatgatggtgggaatgatgctgaacttccctgccttgccgttcaccatcacgtc, 5Ј-tattaccgagacgcagccggggt, and 5Ј-agctcgagtcacgtgctcctgtggggctccag. The fragment obtained with overlap extension, which contained the inserted exon 10, was digested with BamHI and XhoI and was used to replace the sequence between BamHI site inside the P2X 5 receptor cDNA and the downstream XhoI site in the vector. This procedure essentially removed all the 3Ј nontranslated region of the EST clone. The full-length coding sequence was subcloned into pcDNA3.1Zeo(ϩ) with HindIII and XhoI.
For comparison of expression levels between human P2X 5 and rat P2X 5 receptors we used a C-terminal EYMPME (EE) epitope (Kim et al., 2001a) . We also truncated the receptors at a position corresponding to the end of exon 11 ; the final amino acid of these constructs was Gly 378 in both the human and rat receptors; this construct is termed P2X 5 ⌬C (Fig. 1A) . The full-length and truncated forms of the human receptor were also subcloned into pEGFP-N2 or pEGFP-N3 vectors (BD Biosciences Clontech, Palo Alto, CA) to make P2X 5 -EGFP and P2X 5 ⌬C-EGFP. We made pointmutated receptors using QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA).
Transient Transfections, GFP Fluorescence, and Immunoblots. The methods were as described in detail previously (Kim et al., 2001a,b) . In brief, HEK293 cells were plated in 35-mm Petri dishes, transfected using LipofectAMINE 2000 (Invitrogen) (1 g of cDNA/2 ϫ 10 5 cells), and studied 24 to 48 h after transfection. GFP-fused P2X 5 receptors were plated on glass coverslips, fixed for 10 min with 4% paraformaldehyde, washed twice with physiological saline, and photographed using a CCD camera and an Olympus BX40 fluorescence microscope. Immunoprecipitation and Western blots were carried out using EE-tagged P2X 5 receptors as described previously (Kim et al., 2001a,b) . Protein was bound to anti-EE monoclonal antibody (BabCo, Richmond, CA) and precipitated with ␥-bind G-Sepharose (Amersham Biosciences, Uppsala, Sweden). Immune complex was then dissociated from ␥-bind G-Sepharose, applied to SDS-PAGE, and blotted with anti-EE polyclonal Ab. Molecular weights were calculated using GeneSnap and GeneTools software (Syngene, Cambridge UK).
Electrophysiology and Fluorescent Imaging. Whole-cell patch clamp recordings were obtained using a HEKA EPC9 amplifier and Pulse software (HEKA, Lambrecht Germany) as described previously (Virginio et al., 1998a; Jiang et al., 2001 In these experiments, solution exchange times were estimated from changes in junction potentials when a solution of 147 mM potassium gluconate was applied; these averaged 80 ms. Antagonists were applied for 1 to 4 min before, and throughout, agonist applications; agonist applications were repeated at 2-to 4-min intervals.
For reversal potential measurements, the whole-cell configuration was established in standard external solution and the external solution was changed to solution 147NaCl; the reversal potential was obtained by a ramp voltage command (Ϫ120 to 40 mV; 1-s duration). The solution was then exchanged with one of solutions described above, and the reversal potential was measured again. The reversal potentials reported have been corrected for liquid junction potentials, which were calculated using Henderson's equation (Ives and Janz, 1961) , and in any case did not exceed 4 mV. The permeability ratios (P X /P Na ) were derived from the reversal potentials (E rev ) as follows [where x ϭ E rev F/R T (F is the Faraday constant, R is the gas constant, and T is the absolute temperature)]:
The estimate of P Cl /P Na (0.52) was used for further estimates of permeability ratios.
For solution 110CaCl 2 :
For solution 147NMDG:
For solution 147gluc: P gluc /P Na ϭ (CϩD)/F where
Ion concentrations were converted to activities using the following coefficients: ␥ Na ϭ 0.75, ␥ Cl ϭ 0.75, ␥ Ca ϭ 0.28, ␥ NMDG ϭ 0.81, and ␥ gluc ϭ 0.81.
YO-PRO-1 fluorescence was measured as described previously (Virginio et al., 1999a) ; we used a Zeiss Axiovert 100 and Fluar 20ϫ objective with Photonics monochrometer imaging (Photonics, Germany). Data Analysis. Figures show mean Ϯ S.E.M for number of cells and curves fitted from pooled data using Kaleidagraph (Synergy Software, Reading PA). Onset and offset of ATP action were approximated by single exponentials of time constant on and off ; the corresponding rate constants (k 1 ϭ {(1/ on ) Ϫ k Ϫ1 }/[ATP] and k Ϫ1 ϭ 1/ off ) were assumed to be related to membrane potential by an expression of the form
where V is the membrane potential, ␦ is the fraction of the membrane electric field acting on a sensor of valence z, and k(0) is the rate constant at 0 mV. Agonist concentration-response curves were fit by I/I max ϭ 100 
Results
Expression of Human P2X 5 Receptor. Transfection of HEK293 cells with either human P2X 5 or rat P2X 5 receptor cDNAs resulted, within 1 to 2 days, in strong expression of the protein (Fig. 1, B and C). Immunoblotting of proteins from these cells showed single bands at 61 and 62 kDa, respectively (Fig. 1B) , which is appropriate to glycosylated proteins with calculated molecular masses of the two P2X 5 proteins (51 and 52 kDa). This was primarily localized to the plasma membrane by immunocytochemistry (Fig. 1C) . Although Western blotting showed equivalent protein expression of the rat and human P2X 5 receptor, currents evoked by ATP at the rat P2X 5 receptor were extremely small (Ͻ50 pA in these experiments; see also Collo et al., 1996; GarciaGuzman et al., 1996) , whereas ATP-evoked currents at the human P2X 5 receptor were large (1-5 nA at Ϫ60 mV) (Fig. 2) . We observed no significant differences in the immunohistochemistry or in the ATP-evoked currents between HEK293 cells transfected with an epitope-tagged human P2X 5 receptor (hP2X 5 -EE) or with an EGFP-fused hP2X 5 receptor (hP2X 5 -EGFP) (Fig. 1C) ; therefore, we have included some experiments with these constructs in the results of the functional experiments.
Agonist and Antagonist Actions at Human P2X 5 Receptor. Application of ATP (0.3-3 M; 1-5 s) evoked inward currents (at Ϫ60 mV) that were sustained; the currents elicited by higher concentrations declined during the application ( Fig. 2A) . Concentration-response curves for ATP, BzATP, and ␣␤meATP yielded EC 50 values of 4.1 Ϯ 0.5 (n ϭ 5), 5.7 Ϯ 0.9 (n ϭ 5), and 161 Ϯ 35 M (n ϭ 4), respectively (Fig. 2B) . BzATP, ␣␤meATP, and 2-methylthio-ATP elicited Ͼ85% of the maximal ATP current; adenosine-5Ј-O-(3-thio)triphosphate, ADP, and ␤␥-methylene-ATP acted as less full agonists (Fig. 2C) . Thus, the sensitivity to ␣␤meATP is much greater than that observed for the rat P2X 5 receptor (no effect of 300 M ␣␤meATP; Collo et al., 1996) , somewhat greater than that found for the rat P2X 2 receptor (Spelta et al., 2002) but considerably less than that reported for P2X 1 , P2X 3 , P2X 2/3 , and rP2X 1/5 receptors (see North and Surprenant, 2000) .
PPADS, Brilliant Blue G (BBG), and suramin inhibited the ATP-evoked current; this was concentration-dependent with IC 50 values of 0.2 Ϯ 0.02 (n ϭ 3), 0.53 Ϯ 0.04 (n ϭ 3), and 2.9 Ϯ 0.4 (n ϭ 5) ⌴, respectively (Fig. 2D) . The sensitivity to inhibition by PPADS observed for the human P2X 5 receptor is about 10-fold higher than previously reported for other heterologously expressed P2X receptors . The inhibition by BBG is intermediate between the high sensitivity of the rat and human P2X 7 receptor (IC 50 , 10 and 200 nM, respectively) and the very low sensitivity of the other P2X receptors (IC 50 values Ͼ5-10 M) (Jiang et al., 2000) . 2Ј,3Ј-O-(2Ј,4Ј,6Ј-Trinitrophenol)-ATP, which is a nanomolar affinity antagonist at the P2X 1 , P2X 3 , and P2X 2/3 receptors (Virginio et al., 1998b; North and Surprenant, 2000) , only minimally inhibited the ATP-evoked currents at the human P2X 5 receptor (11 Ϯ 5% inhibition at 1 M, n ϭ 3).
Kinetics of Agonist Action. There were some features of the action of ATP that differed from those observed previously at other P2X receptors. First, the onset of the current was slower. We measured on at the human P2X 5 and rat P2X 2 receptors under the similar conditions using near-maximal ATP concentrations (10 and 30 M, respectively; holding potential, Ϫ60 mV); the values were 410 Ϯ 50 ms (n ϭ 8) and 161 Ϯ 10 ms (n ϭ 4). The rate of onset of the current showed little if any dependence on membrane potential (Fig.  3A) , but the rate of the offset of the response upon removal of agonist was almost 10-fold slower at ϩ30 mV than at Ϫ60 mV (Fig. 3, B and C) . The offset rate constant was 0.2/s at 0 mV, and the fraction of the membrane field sensed by the channel closing (assuming a monovalent sensor) was 0.6. The offset of the current at the rat P2X 2 receptor was some 10 times faster and was not voltage-dependent ( off was about 300 ms at all potentials; Fig. 3C ).
The desensitization of the current that occurred with longer agonist applications was also voltage-dependent (Fig.  3A) . At a holding potential of Ϫ30 mV, the current at the end of a 10-s application of ATP (3 M) had declined to 48 Ϯ 11% (n ϭ 6) of its peak value; the corresponding value at ϩ30 mV was 86 Ϯ 3% (n ϭ 8). The ATP-evoked current at the chick and bullfrog P2X 5 receptor shows rapid desensitization (at Ϫ60 mV) that is prevented by removal of external calcium (Bo et al., 2000; Ruppelt et al., 2001) . However, in the present study on the human P2X 5 receptor, removal of calcium from the superfusion solution did not alter the ATP concentrationresponse curve (n ϭ 3), the onset or offset kinetics of the ATP current at any membrane potential (n ϭ 6), or the desensitization during the continued presence of agonist (n ϭ 3).
Ion Permeability. We investigated the ion permeability at the human P2X 5 receptor by measuring reversal potentials with patch pipettes containing 147 mM NaCl, and changing the composition of the external solutions. The reversal potential in solution 147NaCl was Ϫ0.4 Ϯ 1.1 mV (n ϭ 6). We first estimated P Cl /P Na with solution 40NaCl (Fig. 4) . Table 1 shows that the shift in reversal potential (Ϫ12 mV) was much less than expected for a chloride-impermeable channel (the theoretical value would be Ϫ33 mV). Thus, the human P2X 5 receptor has a very significant permeability to chloride ions (P Cl /P Na , 0.5; Table 1), and this was taken into account in estimates of other permeability ratios when chloride ions were present (see Materials and Methods). We substituted extracellular chloride with gluconate (solution 147gluc) and found that gluconate permeability was insignificant (Table 1) . By using extracellular NMDG (solution 154NMDG) and calcium chloride (solution 110CaCl 2 ), we found that that the human P2X 5 receptor was quite permeable to NMDG (P NMDG /P Na , 0.37) and calcium (P Ca /P Na , 1.5) ( Fig. 4; Table 1 ). Parallel experiments were carried out for direct comparison on cells expressing the rat P2X 2 and P2X 2/3 receptors; we found that these receptors have very low permeability to NMDG (P NMDG /P Na Ͻ 0.05) (see also Virginio et al., 1999b) and chloride (P Cl /P Na Ͻ 0.02) ions (Table 1) .
The significant difference in chloride permeability between the human P2X 5 receptor and the P2X 2 receptor led us to search for amino acid residues in or around the transmembrane domains that might differ between the two channels. A possible candidate is Lys 52 of the hP2X 5 receptor, which corresponds in position to Gln 52 of the rat P2X 2 receptor; P2X 5 receptors are unusual in having lysine in this position, where P2X 1 , P2X 2 , P2X 3 , P2X 4 , and P2X 7 subunits have a negatively charged side chain (Gln, Asp, Asn, or Glu). This 
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position is at the outer end of the first transmembrane domain, and we speculated that the difference in charge might contribute to the difference in anion permeability. We reversed the charge by mutagenesis and measured the P Cl /P Na ratios. The value for the human P2X 5 receptor was not different from wild type, and the rat P2X 2 receptor with the complementary mutation [Q52K] remained impermeable to chloride (Table 1 ).
In the case of the P2X 7 receptor Virginio et al., 1999b) , the permeability to NMDG is very low at the beginning of the ATP application and progressively increases over several seconds. Indeed, when the application of agonist is kept brief (Ϸ2 s), there is no significant permeability to NMDG . NMDG permeability has also been found for the P2X 2 and P2X 4 receptor, but in these cases, it also develops during several seconds of agonist application (Khakh et al., 1999; Virginio et al., 1999b) . This progressive increase in permeability is detected as a time-dependent change in reversal potential during a sustained application of agonist. We therefore directly compared the kinetics of NMDG permeability at the rat P2X 7 and the human P2X 5 receptors under the same conditions (Fig.  5) . As reported previously (Virginio et al., 1999a,b) , the reversal potential in NMDG chloride shifted over an exponential time course from about Ϫ90 mV (P NMDG /P Na Ͻ 0.02) in the first several seconds of agonist application to a steadystate value of approximately Ϫ21 mV (P NMDG /P Na 0.25) after 30 s (Fig. 5, B and C) . However, for the human P2X 5 receptor, the reversal potential in NMDG chloride was Ϫ15 Ϯ 2 mV (n ϭ 7) as soon as it was feasible to measure it (1-4 s after ATP application) and did not change during the subsequent 30 s of receptor stimulation (Fig. 5, A and C) . Indeed, the onset kinetics of the inward current were no different in solutions containing sodium or NMDG as the only extracellular cation (Figs. 3 and 5 ), indicating that, within our resolution, the channel is NMDG-permeable from the time at which it opens. The permeability to NMDG was observed in external solutions containing no divalent cations (used for more accurate measurement of reversal potentials), but it was also observed in solutions containing NMDG, calcium (2 mM), and magnesium (1 mM) (n ϭ 4).
YO-PRO-1 Permeability of Human P2X 5 Receptor. YO-PRO-1 is a propidium dye that becomes fluorescent when it intercalates nucleic acid. We followed its entry into cells by fluorescence imaging. We compared the rate of YO-PRO-1 uptake induced by ATP and BzATP at the human P2X 5 and rat P2X 7 receptors (Fig. 6) . Neither BzATP (100 M) nor ATP (1 mM) evoked any YO-PRO-1 fluorescence in mock-transfected HEK293 cells (n Ͼ 40 cells from three separate experiments; Fig. 6A ). The absolute fluorescence measured 60 s after the addition of a maximal concentration of either ATP or BzATP was ϳ2-fold greater at the human P2X 5 receptor (Fig. 6A) , whereas the rate of YO-PRO-1 uptake was almost 4-fold greater at the human P2X 5 receptor (Fig. 6B) . For the rat P2X 7 receptor, the rate of YO-PRO-1 uptake was greater when the external solutions contained no divalent cations (see Surprenant et al., 1996) , but this difference was not present for the P2X 5 receptor (Fig. 6B) .
Comparison of Human and Rat P2X 5 Receptors. We were struck by the robust expression of ionic currents by HEK cells transfected with the human P2X 5 receptor, compared with the rat P2X 5 receptor (Collo et al., 1996; GarciaGuzman et al., 1996) . Moreover, there were clear functional 
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differences between the properties of the two homomers (e.g., increased sensitivity to ATP and ␣␤meATP, voltage-dependent kinetics). We sought to determine whether these differences might be related to the different C-terminal regions between the two receptors (Fig. 1A) . In general, the C-terminal regions of the P2X receptors show little conservation of sequence among the seven subtypes, but within each subtype, there is significant homology among species orthologs. However, for the P2X 5 receptor, the C-terminal regions are related in sequence only between rat and mouse but not in the case of bullfrog, zebrafish, chicken, and human; in these species, all relatedness ends at the splice site between exons 11 and 12 . We therefore compared the properties of the human and rat receptors truncated at this point (Fig. 1A) . Both truncated receptors (with C-terminal EGFP fusions) localized to the plasma membrane in a manner similar to that of the wildtype receptors, although they both showed a lower level of immunofluorescence than did the wild type. The maximum current amplitudes were slightly lower in each of the truncated receptors compared with their respective wild-type receptors. The maximum ATP-evoked currents at wild-type and truncated rat P2X 5 receptors were 49 Ϯ 14 pA and 28 Ϯ 9 pA (n ϭ 10 each); at wild-type and truncated human P2X 5 receptor, maximum currents were 2.9 Ϯ 0.5 and 0.95 Ϯ 0.1 nA (n ϭ 9 each). However, no other significant differences in the functional properties were observed. The EC 50 for ATP was 3.3 Ϯ 0.2 M (n ϭ 3) at the truncated human P2X 5 receptor; ␣␤meATP (100 M) did not evoke any current at the truncated rat P2X 5 receptor but was almost a full agonist at the truncated human P2X 5 receptor (n ϭ 4), and the truncated human P2X 5 receptor also showed a voltage-dependence time course of current offset (n ϭ 5).
There are three amino acid differences between human and rat receptors in the part of the protein encoded by exon 10. We made a chimeric receptor in which the sequence coded by exon 10 from the rat receptor was used to replace the equivalent sequence of the human receptor. The resulting human receptor [P2X 5 , V337I/V340I/V344L] had properties indistinguishable from those of the human P2X 5 receptor. There are only minor differences between the human and rat P2X 5 receptors in the regions before and including the first transmembrane domain (1-50) and between the end of the second transmembrane domain and the truncation point (334-379); it is likely that different residues in the ectodomains may account for the different properties.
Discussion
Our work shows that a P2X 5 receptor containing all 13 exons encoded by the human gene expresses well in HEK293 cells and produces robust currents in response to ATP. It has previously been well documented that the form of the receptor that does not contain exon 10 can not form homomeric channels despite apparently good membrane expression (Lê et al., 1997) . Human tissues seem to contain more P2X receptor forms that are spliced so as to produce nonfunctional proteins than are found in rodent orthologs (e.g., P2X 2 , Lynch et al., 1999; P2X 6 , Urano et al., 1997; see North, 2002) ; this might reflect a loss of function during evolution. The presence of a polymorphism at a critical position in the human P2X 5 gene strongly indicates that a subset of humans will process and translate their RNA to make the protein that we have expressed. Presumably, mice and chickens also make a protein corresponding to the 'full-length' 13-exon form (see Introduction).
When expressed in mammalian cells or oocytes from cDNAs, the human (this study), chick (Bo et al., 2000; Ruppelt et al., 2001) , and bullfrog (Jensik et al., 2001 ) P2X 5 receptors express well; it is less clear why currents at the rat (this study; Collo et al., 1996; Garcia-Guzman et al., 1996) , mouse , and zebrafish receptors (Diaz-Hernandez et al., 2002) do not. The rat sequence contains in its C terminus a sequence Arg 404 -Val-Arg; this is similar in the mouse (Arg 404 -Val-His). The RXR motif is a well known endoplasmic reticulum retention motif and has been implicated in the trafficking of several ion channels to the plasma membrane (Ma and Jan, 2002) . We mutated this sequence to Ala-Ala-Ala in the rat P2X 5 receptor but found that the currents recorded from transfected HEK293 cells were still very small (L.-H. Jiang, unpublished observations). In any event, using Western blotting and immunohistochemistry, we detected no obvious difference between the expression of rat and human P2X 5 receptors.
Compared with other homomeric P2X receptors, the pharmacological profile of the human P2X 5 receptor is most similar to the P2X 2 receptor . It is rather more sensitive to the agonists ATP (EC 50 Ϸ 5 M) and ␣␤meATP (EC 50 Ϸ 150 M) and the antagonist PPADS (IC 50 Ͻ 1 M). The current shows much less rectification than is observed for the P2X 2 receptor; in this respect, it is more similar to homomeric P2X 4 and P2X 7 receptors (see North, 2002) . Compared with P2X 5 receptors from other species [chick (Bo et al., 2000; Ruppelt et al., 2001 ) and bullfrog (Jensik et al., 2001) ], the most noticeable difference is the relatively slower desensitization of the current at the human receptor. As seen for the chick receptor (Ruppelt et al., 2001) , we observed that holding the membrane potential at positive could largely prevent desensitization. In the chick, calcium entry might contribute to the desensitization because removing the extracellular calcium ions also prevented it; we did not find this to be the case for the human P2X 5 receptor.
The kinetics of channel opening, as best we could estimate with the present approach, corresponded to a macroscopic k ϩ1 of 1 M/s, which is approximately similar to that observed for P2X 2 receptors (Ding and Sachs, 1999) ; this rate showed only little voltage dependence. On the other hand, the rate of decline of the current ranged from 1/s at Ϫ60 mV to 0.15/s at ϩ30 mV (Fig. 2) . This is in contrast to the rat P2X 2 receptor, where the offset of current shows little or no voltage-dependence (Fig. 2) . Taken together, the results indicate that depolarized membrane potentials tend to stabilize the human P2X 5 receptor in an open state, from which it less easily enters either a desensitized or a closed state.
The permeability of the human P2X 5 receptors also shows several unique features. Our measurements of reversal potential when the concentration of extracellular sodium chloride ions was reduced to 40 mM indicate clearly that the channel has substantial chloride permeability (P Cl /P Na Ϸ 0.5). Although it has been widely assumed that P2X receptors are cation-selective, this has often not been tested directly in heterologous expression systems. In the present study, we measured the reversal potential for currents at the homomeric P2X 2 and heteromeric P2X 2/3 receptors; these corresponded to the theoretical value for a channel that was impermeable to chloride (Table 1) . However, the chick P2X 5 receptor has substantial chloride permeability (Ruppelt et al., 2001) ; their value for P Cs /P Cl of about 2 corresponds well with our present measurement for the human P2X 5 receptor (if we assume that P Na Ϸ P Cs ). The molecular basis for the relative high permeability to chloride ions is not understood. We noticed a lysine residue near the outer end of the first transmembrane domain of the P2X 5 receptor sequences. Of the other P2X receptor subunits, lysine is found only in P2X 6 and no permeability information is available; the residue at this position is negatively charged in all the other subunits. However, we were unable to change the chloride permeability by making the appropriate amino acid exchanges at this position. Further knowledge of the anion permeabilities of other (homomeric) P2X receptors would be very helpful to inform the continuation of such a mutagenesis approach to the structural basis of chloride permeability in the human P2X 5 channel.
The chloride permeability of the receptor is of particular interest because ATP-activated currents in skeletal muscle have been repeatedly shown to involve a chloride permeability. The original evidence that ATP directly gates the opening of ion channels was based on whole-cell and single-channel recordings from embryonic chick skeletal muscle myotubes (Kolb and Wakelam, 1983) . Subsequent studies in chick and frog showed striking developmental regulation of these channels; they disappear during late embryogenesis but reappear in the adult after denervation (Hume and Honig, 1986; Igusa, 1988; Thomas and Hume, 1990a; Thomas et al., 1991; Wells et al., 1995) . They are also characterized by both cation permeability and a "substantial increase in chloride permeability" (Hume and Thomas, 1988; Thomas and Hume, 1990b) . More recently, chick embryonic skeletal muscle has been shown to express high levels of both P2X 5 and P2X 6 receptor immunoreactivity, which disappears with development (Meyer et al., 1999) .
All these observations might be consistent with the notion that ATP-gated channels in embryonic chick skeletal muscle are composed of P2X 5 receptors. There is, however, evidence against the view that the chick receptor is homomeric P2X 5 . For example, ␣␤meATP was ineffective at the receptor on muscle cells cultured from 10-or 11-day-old chick embryos (Hume and Honig, 1986; Thomas et al., 1991) , whereas it does activate currents in oocytes expressing chick P2X 5 receptors (EC 50 Ϸ 30 M; Ruppelt et al., 2001) . A recent study of ATP-gated currents and intracellular calcium responses in mouse and human skeletal muscle has shown a similar developmental pattern of expression of ATP-activated responses as that observed in chick. The ATP responses activated by ATP and BzATP, but they were activated only very weakly by ␣␤meATP, and they showed no desensitization (Cseri et al., 2002) . As for the chick, these observations suggest that the native mammalian receptor is not likely to be homomeric P2X 5 . The predominant expression of P2X 6 subunits in skeletal muscle (Urano et al., 1997) suggests that possibility that the native receptor might include both P2X 5 and P2X 6 subunits. A functional role for ATP in the differentiation of rat skeletal muscle has recently been suggested (Ryten et al., 2002) . The regeneration of skeletal muscle cells after damage involves resident satellite cells being stimulated to differentiate into myotubes. ATP stimulated this differentiation, and evidence from immunohistochemistry, reverse transcription-polymerase chain reaction, and electrophysiology strongly implicated involvement of the P2X 5 subunit.
The cation permeation properties of the human P2X 5 receptor also exhibit some novel features. Permeability to the large cation NMDG has been demonstrated in the case of homomeric P2X 2 , P2X 4 , and P2X 7 receptors and heteromeric P2X 2/3 receptors (Virginio et al., 1999a,b; Khakh et al., 1999) . The human P2X 5 receptor is also permeable to NMDG and the relative permeability (Table 1 ; P NMDG /P Na ϭ 0.37) is similar that described previously for the other receptors. The striking difference for the human P2X 5 receptor is that there is no detectable time delay in the development of the NMDGpermeable state. NMDG permeability was also reported for oocytes expressing the bullfrog P2X 5 receptor, but this was only observed when the extracellular solution contained no divalent cations (Jensik et al., 2001) ; it seemed to develop over several seconds, but it is difficult to make direct kinetic comparisons when whole oocytes and small mammalian cells are used as expression systems. YO-PRO-1 is a larger cation than NMDG (19 ϫ 10 ϫ 5.5 Å compared with 10 ϫ 7.6 ϫ 5.5 Å) and divalent rather than monovalent. It has the advantage that its permeation can be followed in physiological solutions, which is of course not possible when reversal potentials are measured. Human P2X 5 receptors exhibit uptake of YO-PRO-1, which is at least as robust as that observed for P2X 7 receptors ( Fig. 5 ; also Surprenant et al., 1996; Rassendren et al., 1997) . It is not possible to say from these experiments how rapidly the permeability to YO-PRO-1 develops in human P2X 5 receptors, but it would seem to be considerably slower than that observed for NMDG.
In summary, we have constructed and expressed a human P2X 5 receptor cDNA and characterized some of its pharmacological and biophysical properties. Several of these properties are quite distinct from those of other mammalian P2X receptors. These include a significant permeability to chloride ions, which is of interest because skeletal muscle expresses abundant P2X 5 receptor subunits and because ATPactivated currents in skeletal muscle are also chloridepermeable. There is permeability to the large cation NMDG that seems to develop as quickly as that to sodium ions; in other P2X receptors, the increase in NMDG permeability occurs only several seconds after the initial increase in sodium permeability. Finally, we have drawn attention to a single-nucleotide polymorphism that will effectively determine whether an individual organism makes a functioning P2X 5 receptor or a nonfunctional form that lacks exon 10.
